Literature DB >> 32865557

Representation of Women in Cardiovascular Clinical Trial Leadership.

Kara J Denby1, Natalie Szpakowski1, Julie Silver2, Mary Norine Walsh3, Steve Nissen1, Leslie Cho1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32865557      PMCID： PMC7489421          DOI： 10.1001/jamainternmed.2020.2485

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Falling off the academic bandwagon. Women are more likely to quit at the postdoc to principal investigator transition.

Authors:  Elisabeth D Martinez; Jeannine Botos; Kathleen M Dohoney; Theresa M Geiman; Sarah S Kolla; Ana Olivera; Yi Qiu; Geetha Vani Rayasam; Diana A Stavreva; Orna Cohen-Fix
Journal:  EMBO Rep       Date:  2007-11       Impact factor: 8.807

Review 2.  How do we attract and retain women in cardiology?

Authors:  Emily S Lau; Malissa J Wood
Journal:  Clin Cardiol       Date:  2018-02-26       Impact factor: 2.882

3.  Gender-heterogeneous working groups produce higher quality science.

Authors:  Lesley G Campbell; Siya Mehtani; Mary E Dozier; Janice Rinehart
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

4.  The possible role of resource requirements and academic career-choice risk on gender differences in publication rate and impact.

Authors:  Jordi Duch; Xiao Han T Zeng; Marta Sales-Pardo; Filippo Radicchi; Shayna Otis; Teresa K Woodruff; Luís A Nunes Amaral
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240
  4 in total
  10 in total

1.  Global representation of heart failure clinical trial leaders, collaborators, and enrolled participants: a bibliometric review 2000-20.

Authors:  Jie Wei Zhu; NhatChinh Le; Sunny Wei; Liesl Zühlke; Renato D Lopes; Faiez Zannad; Harriette G C Van Spall
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-09-05

Review 2.  A roadmap of strategies to support cardiovascular researchers: from policy to practice.

Authors:  Niamh Chapman; Emma E Thomas; Joanne T M Tan; Sally C Inglis; Jason H Y Wu; Rachel E Climie; Dean S Picone; Lauren C Blekkenhorst; Steven G Wise; Katrina M Mirabito Colafella; Anna C Calkin; Francine Z Marques
Journal:  Nat Rev Cardiol       Date:  2022-05-16       Impact factor: 49.421

Review 3.  Are we any WISER yet? Progress and contemporary need for smart trials to include women in coronary artery disease trials.

Authors:  Ana Iribarren; Márcio Augusto Diniz; C Noel Bairey Merz; Chrisandra Shufelt; Janet Wei
Journal:  Contemp Clin Trials       Date:  2022-04-20       Impact factor: 2.261

4.  National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020.

Authors:  Devesh Rai; Syed Hamza Waheed; Miranda Guerriero; Muhammad Waqas Tahir; Ritambhara Pandey; Harsh Patel; Samarthkumar Thakkar; Sharon L Mulvagh; Alexandra Bastiany; Shelley Zieroth; Colleen M Norris; Harriette G C Van Spall; Erin D Michos; Martha Gulati
Journal:  CJC Open       Date:  2021-04-10

5.  Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys.

Authors:  David D Waters
Journal:  CJC Open       Date:  2021-08-08

6.  Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap.

Authors:  Nosheen Reza; Jadry Gruen; Biykem Bozkurt
Journal:  Am Heart J Plus       Date:  2022-01-30

7.  Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.

Authors:  Erin D Michos; Tina K Reddy; Martha Gulati; LaPrincess C Brewer; Rachel M Bond; Gladys P Velarde; Alison L Bailey; Melvin R Echols; Samar A Nasser; Harold E Bays; Ann Marie Navar; Keith C Ferdinand
Journal:  Am J Prev Cardiol       Date:  2021-08-20

8.  Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs.

Authors:  Izza Shahid; Muhammad Shahzeb Khan; Aruba Sohail; Safi U Khan; Stephen J Greene; Marat Fudim; Erin D Michos
Journal:  JAMA Netw Open       Date:  2022-02-01

9.  Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide.

Authors:  Maishara Muquith; Tri Pham; Magdalena Espinoza; David Hsiehchen
Journal:  JAMA Netw Open       Date:  2022-02-01

10.  Dementia clinical trials over the past decade: are women fairly represented?

Authors:  Ana-Catarina Pinho-Gomes; Jessica Gong; Katie Harris; Mark Woodward; Cheryl Carcel
Journal:  BMJ Neurol Open       Date:  2022-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.